Elanco Makes Acquisition Published August 2, 2019 Elanco Animal Health has acquired a Canadian biotechnology firm called Prevtec Microbia. Prevtec Microbia develops vaccines to help prevent bacterial diseases in food animals. The deal was valued at $60 million. Share this:
